HDAC6 and Heat Shock Protein 90 (Hsp90) are key regulatorswithinthe androgen response pathway, exhibiting a close interplay and mutualinteraction patterns that make their combined inhibition a promisingstrategy for treating aggressive prostate cancer (PC). This evidence concerns the gene HDAC6 and prostate cancer.